Tumor necrosis factor-α induces interleukin-6 production via extracellular-regulated kinase 1 activation in breast cancer cells

Breast Cancer Research and Treatment

Volumn 80, Issue 1, 2003, Pages 71-78

  Suarez Cuervo, Catalina ^a   Harris, Kevin W ^a,b   Kallman, Lisa ^a   Väänänen, H Kalervo ^c   Selander, Katri S ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Breast cancer; Interleukin 11; Interleukin 6; Mitogen activated protein kinases

Indexed keywords

INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL;

BLOTTING, WESTERN; BREAST NEOPLASMS; ENZYME ACTIVATION; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-11; INTERLEUKIN-6; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037823236     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024443303436     Document Type: Article

References (46)

1. Elte JWF, Bijvoet OLM, Cleton FJ, van Oosterom AT, Sleeboom HP: Osteolytic bone metastases in breast carcinoma: pathogenesis, morbidity and bisphosphonate treatment. Eur J Cancer Clin Oncol 22: 493-500, 1986
2. Galasko CSB: Mechanisms of bone destruction in the development of skeletal metastases. Nature 263: 507-508, 1976
3. Roodman GD: Biology of osteoclast activation in cancer. J Clin Oncol 19: 3562-3571, 2001
4. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, Yoneda T, Mundy GR: Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98: 1544-1549, 1996
5. Yin JJ, Selander K, Chirgwin JM, Dallas M, Grubbs BG, Wieser R, Massagué J, Mundy GR, Guise TA: TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 2(103): 197-207, 1999
6. Tumber A, Morgan HM, Meikle MC, Hill PA: Human breast-cancer cells stimulate the fusion, migration and resorptive activity of osteoclasts in bone explants. Int J Cancer 91(5): 665-672, 2001
7. Winding B, Misander H, Sveigaard C, Therkildsen B, Jakobsen M, Overgaard T, Oursler MJ, Foged NT: Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis. J Cancer Res Clin Oncol 126: 631-640, 2000
8. Pederson L, Winding B, Foged NT, Spelsberg TC, Oursler MJ: Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Cancer Res 59: 5849-5855, 1999
9. Girasole G, Passeri G, Jilka RL, Manolagas SC: Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 93: 1516-1524, 1994
10. Hirano T: Interleukin-6 and its receptor: ten years later. Int Rev Immunol 16: 249-284, 1998
11. Crichton MB, Nichols JE, Zhao Y, Bulun SE, Simpson ER: Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol Cell Endocrinol 118: 215-220, 1996
12. Lacroix M, Siwek B, Marie PJ, Body JJ: Production and regulation of interleukin-11 by breast cancer cells. Cancer Lett 127: 29-35, 1998
13. Sotiriou C, Lacroix M, Lespagnard L, Larsimont D, Paesmans M, Body JJ: Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases. Cancer Lett 169: 87-95, 2001
14. Zhang Y, Fujita N, Ohara T, Morinaga Y, Nakagawa T, Yamada M, Tsuruo T: Production of interleukin-11 in bone-derived endothelial cells and its role in the formation of osteolytic bone metastases. Oncogene 16: 693-703, 1997
15. Hjertner Ø, Lyngaas M, Torgersen M, Seidel C, Hjorth-Hansen H, Waage A, Børset M, Sundan A: Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease. Blood 94: 3883-3888, 1999
16. Tamm I, Cardinale I, Sehgal PB: Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells. Cytokine 3: 212-223, 1991
17. Arihiro K, Oda H, Kaneko K, Inai K: Cytokines facilitate chemotactic motility of breast carcinoma cells. Breast Cancer 7: 221-230, 2000
18. Barton BE: IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation Immunol Res 23: 41-58, 2001
19. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC, Martin TJ: Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51: 3059-3061, 1991
20. Mundy GR: Factors which stimulate bone growth in vivo. Growth Regulat 3: 124-128, 1993
21. Suen Y, Chang M, Lee SM, Buzby JS, Cairo MS: Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood 84: 4125-4134, 1994
22. Morinaga Y, Fujita N, Ohishi K, Tsuruo T: Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-beta and tumor cell factors. Int J Cancer 71: 422-428, 1997
23. Elias JA, Zheng T, Whiting NL, Trow TK, Merrill WW, Zitnik R, Ray P, Alderman EM: IL-1 and transforming growth factor-beta regulation of fibroblast-derived IL-11. J Immunol 152: 2421-2429, 1994
24. Elias JA, Tang W, Horowitz MC: Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 136: 489-498, 1995
25. Nozaki S, Sledge Jr GW, Nakshatri H: Cancer cell-derived interleukin 1alpha contributes to autocrine and paracrine induction of pro-metastatic genes in breast cancer. Biochem Biophys Res Commun 275: 60-62, 2000
26. Tang W, Yan L, Yang Y-C, Leng SX, Elisa JA: Transforming growth factor-β stimulates interleukin-11 transcription via complex activating protein-1-dependent pathways. J Biol Chem 273: 5506-5513, 1998
27. Leonard M, Ryan MP, Watson AJ, Schramek H, Healy E: Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Kidney Int 56: 1366-1377, 1999
28. Suzuki M, Tetsuka T, Yoshida S, Watanabe N, Kobayashi M, Matsui N, Okamoto T: The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha-or IL-1beta stimulated rheumatoid synovial fibroblasts. FEBS Lett 465: 23-27, 2000
29. Webb SJ, McPherson JR, Pahan K, Koka S: Regulation of TNF-alpha-induced IL-6 production in MG-63 human osteoblast-like cells. J Dent Res 81: 17-22, 2002
30. Hungness ES, Pritts TA, Luo GJ, Hershko DD, Robb BW, Hasselgren PO: IL-1beta activates C/EBP-beta and delta in human enterocytes through a mitogen-activated protein kinase signaling pathway. Int J Biochem Cell Biol 34: 382-395, 2002
31. Gao H, Parkin S, Johnson PF, Schwartz RC: C/EBP gamma has a stimulatory role on the IL-6 and IL-8 promoters. J Biol Chem 277: 38827-38837, 2002
32. Han J, Richter B, Li Z, Kravchenko V, Ulevitch RJ: Molecular cloning of human p38 MAP kinase. Biochim Biophys Acta 1265: 224-227, 1995
33. Frost JA, Geppert TD, Cobb MH, Feramisco JR: A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. Proc Natl Acad Sci 91: 3844-3848, 1994
34. Käkönen SM, Selander KS, Chirgwin JM, Yin JJ, Burns S, Rankin WA, Grubbs BG, Dallas M, Cui Y, Guise TA: Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via smad and mitogen-activated protein kinase signaling pathways. J Biol Chem 277: 24571-24578, 2002
35. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC: SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233, 1995
36. Long X, Gize EA, Nephew K, Bigsby RM: Evidence for estrogenic contamination of the MAPK inhibitor PD98059. Endocrinology 142: 5390-5393, 2001
37. Liverton NJ, Butcher JW, Claiborne CF, Claremon DA, Libby BE, Nguyen KT, Pitzenberger ST, Selnick HF, Smith GR, Tebben A, Vacca JP, Varga SL, Agarwal L, Dancheck K: Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase. J Med Chem 42: 2180-2190, 1999
38. Lee JR, Koretzky GA: Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes. Eur J Immunol 28: 4188-4197, 1998
39. Attisano L, Wrana JL: Signal transduction by the TGF-beta superfamily. Science 296: 1646-1647, 2002
40. Kondo A, Mogi M, Koshihara Y, Togari A: Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem Pharmacol 61: 319-326, 2001
41. Chae H-J, Kim S-C, Chae S-W, An N, Kim H-H, Lee Z-H, Kim H-R: Blockade of the p38 mitogen-activated protein kinase pathway inhibits inducible nitric oxide synthase and interleukin-6 expression in MC3T3E-1 osteoblasts. Pharmacological Res 43: 275-283, 2001
42. Leonard M, Ryan MP, Watson AJ, Schramek H, Healy E: Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells. Kidney Int 56: 1366-1377, 1999
43. Sotiriou C, Lacroix M, Lagneaux L, Berchem G, Body JJ: The aspirin metabolite salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic cytokines interleukins-6 and -11. Anticancer Res 19: 2997-3006, 1999
44. Guan Z, Baier LD, Morrison AR: p38 mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1beta. J Biol Chem 272: 8083-8089, 1997
45. Scherle PA, Jones EA, Favata MF, Daulerio AJ, Covington MB, Nurnberg SA, Magolda RL, Trzaskos JM: Inhibition of MAP kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. J Immunol 161: 5681-5686, 1998
46. Strakova Z, Copland JA, Lolait SJ, Soloff MS: ERK2 mediates oxytocin-stimulated PGE2 synthesis. Am J Physiol 274: E634-E641, 1998